Related references
Note: Only part of the references are listed.HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy
Cecile Brouard et al.
BMC INFECTIOUS DISEASES (2019)
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices
Scott D. Ramsey et al.
JAMA ONCOLOGY (2019)
Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study
Harrys A. Torres et al.
HEPATOLOGY (2018)
Revealing geographical and population heterogeneity in HIV incidence, undiagnosed HIV prevalence and time to diagnosis to improve prevention and care: estimates for France
Lise Marty et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2018)
Investigating Barriers in HIV-Testing Oncology Patients: The IBITOP Study, Phase I
Laurent Merz et al.
ONCOLOGIST (2016)
HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center
Jessica P. Hwang et al.
JOURNAL OF ONCOLOGY PRACTICE (2015)
Patients with AIDS-defining cancers are not universally screened for HIV: a 10-year retrospective analysis of HIV-testing practices in a Swiss university hospital
V. Mosimann et al.
HIV MEDICINE (2014)
Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients
Parag Mahale et al.
JOURNAL OF HEPATOLOGY (2012)
Share Paper
